Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Ossium Health, Inc.
University of Michigan Rogel Cancer Center
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Instituto Nacional de Cancer, Brazil
Mustang Bio
Columbia University
Roswell Park Cancer Institute
Indiana University
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Columbia University
Asan Medical Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center